158 related articles for article (PubMed ID: 12119038)
1. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities.
De Souza D; Fabri LJ; Nash A; Hilton DJ; Nicola NA; Baca M
Biochemistry; 2002 Jul; 41(29):9229-36. PubMed ID: 12119038
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.
Nicholson SE; De Souza D; Fabri LJ; Corbin J; Willson TA; Zhang JG; Silva A; Asimakis M; Farley A; Nash AD; Metcalf D; Hilton DJ; Nicola NA; Baca M
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6493-8. PubMed ID: 10829066
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of signaling by oncostatin M in human vascular cells involves cytoplasmic Tyr residue 759 in gp130 but is not mediated by either Src homology 2 domain-containing tyrosine phosphatase 2 or suppressor of cytokine signaling 3.
Mahboubi K; Kirkiles-Smith NC; Karras J; Pober JS
J Biol Chem; 2003 Jul; 278(27):25014-23. PubMed ID: 12724316
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
Fairlie WD; De Souza D; Nicola NA; Baca M
Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
[TBL] [Abstract][Full Text] [Related]
5. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
[TBL] [Abstract][Full Text] [Related]
6. Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library.
Beebe KD; Wang P; Arabaci G; Pei D
Biochemistry; 2000 Oct; 39(43):13251-60. PubMed ID: 11052678
[TBL] [Abstract][Full Text] [Related]
7. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
Sweeney MC; Wavreille AS; Park J; Butchar JP; Tridandapani S; Pei D
Biochemistry; 2005 Nov; 44(45):14932-47. PubMed ID: 16274240
[TBL] [Abstract][Full Text] [Related]
8. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
[TBL] [Abstract][Full Text] [Related]
9. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
[TBL] [Abstract][Full Text] [Related]
10. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.
Hörtner M; Nielsch U; Mayr LM; Heinrich PC; Haan S
Eur J Biochem; 2002 May; 269(10):2516-26. PubMed ID: 12027890
[TBL] [Abstract][Full Text] [Related]
11. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
Qin C; Wavreille AS; Pei D
Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
[TBL] [Abstract][Full Text] [Related]
12. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.
Schmitz J; Weissenbach M; Haan S; Heinrich PC; Schaper F
J Biol Chem; 2000 Apr; 275(17):12848-56. PubMed ID: 10777583
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
14. Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position.
Imhof D; Wavreille AS; May A; Zacharias M; Tridandapani S; Pei D
J Biol Chem; 2006 Jul; 281(29):20271-82. PubMed ID: 16702225
[TBL] [Abstract][Full Text] [Related]
15. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor.
Bartoe JL; Nathanson NM
Brain Res Mol Brain Res; 2002 Nov; 107(2):108-19. PubMed ID: 12425940
[TBL] [Abstract][Full Text] [Related]
16. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
17. Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling.
Keilhack H; Tenev T; Nyakatura E; Godovac-Zimmermann J; Nielsen L; Seedorf K; Böhmer FD
J Biol Chem; 1998 Sep; 273(38):24839-46. PubMed ID: 9733788
[TBL] [Abstract][Full Text] [Related]
18. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
[TBL] [Abstract][Full Text] [Related]
19. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.
Hua CT; Gamble JR; Vadas MA; Jackson DE
J Biol Chem; 1998 Oct; 273(43):28332-40. PubMed ID: 9774457
[TBL] [Abstract][Full Text] [Related]
20. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
